Life Science Analytics

Global Life Science Analytics Market to Reach US$74.6 Billion by 2030

The global market for Life Science Analytics estimated at US$35.3 Billion in the year 2024, is expected to reach US$74.6 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$44.7 Billion by the end of the analysis period. Growth in the Software segment is estimated at 12.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.5 Billion While China is Forecast to Grow at 12.1% CAGR

The Life Science Analytics market in the U.S. is estimated at US$9.5 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.1% and 11.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Global Life Science Analytics Market - Key Trends & Drivers Summarized

Why Is Life Science Analytics Becoming Integral to Healthcare and Research?

Life science analytics is becoming integral to healthcare and research as organizations increasingly rely on data-driven insights to improve patient outcomes, accelerate drug development, and enhance operational efficiency. By leveraging advanced analytics tools, such as artificial intelligence (AI) and machine learning, life science companies can analyze vast amounts of data from clinical trials, electronic health records, and genomics to uncover patterns and trends that inform decision-making. This data-driven approach is helping to personalize medicine, optimize clinical trials, and streamline research and development processes, making life science analytics a critical component in the modern healthcare ecosystem.

How Are Technological Advancements Shaping the Life Science Analytics Market?

Technological advancements are significantly enhancing the capabilities and applications of life science analytics. The integration of AI and machine learning algorithms into analytics platforms is enabling more sophisticated data analysis, allowing researchers and healthcare providers to identify insights that were previously difficult or impossible to detect. Cloud computing is also playing a key role by providing scalable and secure environments for storing and processing large datasets. Additionally, advancements in data visualization tools are making it easier for non-technical users to interpret complex data, leading to more informed decision-making across the life sciences industry. These technological innovations are driving the adoption of advanced analytics solutions, fueling growth in the life science analytics market.

What Are the Emerging Trends in the Life Science Analytics Market?

Several emerging trends are shaping the life science analytics market, including the increasing focus on personalized medicine, the growing use of real-world evidence in drug development, and the shift towards value-based care. Personalized medicine, which tailors treatments to individual patients based on their genetic makeup and other factors, is heavily reliant on advanced analytics to identify the most effective therapies. The use of real-world evidence, which involves analyzing data from sources such as electronic health records and patient registries, is also gaining traction as a way to support drug development and regulatory decision-making. Additionally, the shift towards value-based care, which emphasizes patient outcomes and cost-effectiveness, is driving the need for analytics solutions that can track and measure healthcare performance. These trends are contributing to the dynamic growth of the life science analytics market.

What Factors Are Driving the Growth of the Life Science Analytics Market?

The growth in the life science analytics market is driven by several factors, including the increasing adoption of advanced analytics tools in healthcare and research, the growing emphasis on personalized medicine, and the rising need for data-driven decision-making in the life sciences industry. The expansion of healthcare data, generated by electronic health records, clinical trials, and genomics, is a significant driver, as it creates a demand for powerful analytics solutions that can process and interpret this data. Additionally, the push towards value-based care and the use of real-world evidence in drug development are driving the adoption of analytics solutions. As the life sciences industry continues to evolve, the demand for advanced analytics is expected to grow, driving sustained growth in the market.

SCOPE OF STUDY:

The report analyzes the Life Science Analytics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Offering (Services, Software); Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics); Deployment (On-Premise Deployment, Cloud); End-Use (Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities, Third-Party Administrators)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

• Accenture PLC
• Cognizant Technology Solutions Corporation
• IBM Corporation
• IQVIA
• MaxisIT Inc.
• Oracle Corporation
• SAS Institute, Inc.
• SCIO Health Analytics, an EXL company
• TAKE Solutions
• Wipro Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.